Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey.
Aziz KaracaMustafa Nuri GuncikanNazlı Nadire SozmenGizem Gokce KaradagMustafa YilmazKerem KinikFatma Meric YilmazPublished in: Medeniyet medical journal (2021)
An antibody response to SARS-CoV-2 was noted in a CP donor on the 244th day. The average IgG ratios were higher in the CP donors with the AB blood group, but lower in the O blood group. These results may be considered a valuable indication of the effectiveness of CP therapy used for the treatment of COVID-19 patients with clinically relevant blood types.